朝闻国盛：短期可能迎来“决断”

Group 1: Macro Insights - The report suggests that the upcoming months of June and July will be critical for trade negotiations and economic observations, particularly focusing on the U.S.-China and EU trade talks, with a significant meeting scheduled on June 9 [5] - The U.S. economy shows resilience with no signs of recession as of May, and the market expectations for interest rate cuts by the Federal Reserve have been slightly adjusted, indicating a cautious outlook for the next two months [6] Group 2: Market Performance - The stock market is expected to continue its upward trend, with the Shanghai Composite Index rising by 1.13% over the past week, indicating a bullish sentiment among investors [6] - A total of 20 industries are currently in a weekly uptrend, suggesting a broad-based market recovery, with opportunities for investors to position themselves favorably [6] Group 3: Banking Sector - Several banks have announced dividend distributions, with 11 banks having completed their annual dividend distributions by early June, indicating a proactive approach to shareholder returns [21] - The average dividend yield for listed banks is reported at 4.14%, with state-owned banks yielding between 4.3% and 5%, reflecting stable profit growth and a favorable long-term investment outlook [22] Group 4: Coal Industry - The coal price has seen a significant decline from a peak of 1615 RMB/ton in October 2021 to approximately 618 RMB/ton as of June 5, 2025, marking a cumulative drop of 997 RMB/ton [28] - Historical analysis indicates that coal prices typically recover following government intervention or demand-side stimulus, suggesting that policy support will be crucial for future price stabilization [27][28] Group 5: Real Estate Sector - China Resources Vientiane Life is positioned as a leader in commercial operations, with plans to open 6 new shopping centers annually from 2025 to 2028, contributing to revenue growth [31] - The company has demonstrated resilience with a projected retail sales growth of 4.6% in 2024, outperforming the overall retail sector [31] Group 6: Pharmaceutical Sector - The report highlights the transformation of China's innovative drug sector from an importer to an exporter, with a significant increase in the commercialization of innovative drugs [10][11] - The domestic innovative drug market is expected to grow, with the proportion of innovative drugs in medical insurance expenditures rising to 3.19% in 2023, indicating a robust growth trajectory [10] Group 7: Technology Sector - Guokewai plans to acquire a 94.366% stake in Zhongxin Ningbo, which is expected to enhance its capabilities in high-end filters and MEMS, thereby expanding its market reach in smart devices and connected vehicles [42]